CClinicalTrials.gg
CompletedNCT02471950Updated Jun 21, 2021

Isoflurane During Cardiopulmonary Bypass

An observational study in Cardiopulmonary Bypass, Consciousness Monitors and Isoflurane, sponsored by University of Edinburgh. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-06-21.

Sponsored by University of Edinburgh · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
22
Ages
18 Years and older
Sex
All
01

Study summary

There is no clinical way of assessing the depth of anaesthesia while patients are on the heart-lung machine. A new method of measuring the depth of anaesthesia using brainwaves called the Bispectral index (BIS) has been developed and its use in cardiac surgery is now widespread. However BIS is also altered by patients body temperature. As cooling is common during heart surgery the use of BIS to measure the depth of anaesthesia during heart-lung bypass remains controversial. This study aims to find out what depth of anaesthesia is produced according to BIS during heart lung bypass using a standard anaesthetic technique that utilises the anaesthetic isoflurane.

Read the detailed description

There is no clinical way of assessing patients' depth of anaesthesia on the heart-lung machine. For this reason, the amount of volatile anaesthetic agent like isoflurane, that is administered has traditionally been determined by anaesthetists' clinical experience. Recently, a device that assesses depth of anaesthesia by analysing the electrical brain waves called the Bispectral index (BIS) has been introduced. The study aims to determine whether the level of anaesthesia produced by isoflurane using the traditional approach is more than required simply to maintain unconsciousness according to BIS. In addition, the study will determine whether the concentration of isoflurane in exhaust gases from the heart-lung machine can be used as an estimate arterial blood concentration and so, depth of anaesthesia.

The study will recruit patients who are scheduled for heart surgery using a heart-lung machine. Patients will be anaesthetised using a long established balanced technique including the administration of isoflurane 2.5% whilst supported on the heart-lung machine. Measurements of exhaust gas concentration of isoflurane from the heart-lung machine and level of BIS will be recorded at three time points. Simultaneously, three arterial blood samples will be taken and the isoflurane concentration measured in these samples. The BIS levels will be averaged and the proportion of patients with a BIS below 40 (lower limit of normal) will be calculated. Concentrations of isoflurane in the exhaust gas of the heart-lung machine will be compared with blood concentrations of isoflurane and the both concentrations will be compared with the level of BIS to establish whether they can be used to assess depth of anaesthesia.

If this study finds that a large proportion of patients have more than adequate levels of anaesthesia, then future studies could explore whether administering lower concentrations of isoflurane improves outcome whilst maintaining anaesthesia.

02

Conditions studied

  • Cardiopulmonary Bypass
  • Consciousness Monitors
  • Isoflurane
03

In context

Lead sponsor

University of Edinburgh is the lead sponsor of 393 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Those patients scheduled for elective heart surgery over the age of 18 requiring cardiopulmonary bypass

Inclusion criteria

  • Participants over the age of 18
  • Scheduled for elective cardiac surgery under the care of trial anaesthetists
  • Patient has provided informed consent to participate

Exclusion criteria

Exclusion Criteria:

  • Patients presenting for emergency cardiac surgery
  • Patients who will have cardiac surgery that does not require cardiopulmonary bypass
  • Unwilling/unable to provide informed consent
  • Patients under the age of 18
  • Anaesthesia undertaken by anaesthetists not involved in trial
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
22 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Elective Cardiac surgery

    Those patients scheduled for elective heart surgery requiring cardiopulmonary bypass who will be given 2.5% isoflurane while on bypass.

    Procedure: 2.5 % Isoflurane administration

Interventions

  • Procedure2.5 % Isoflurane administration

    Anaesthesia maintained during cardiopulmonary bypass with 2.5% isoflurane administered via the oxygenator of the bypass circuit.

06

What researchers measure

Primary outcomes

  1. Depth of anesthesia according to BIS

    BIS reading will be recorded at three time points during cardiopulmonary bypass

    Time frame: Intraoperative

Secondary outcomes

  1. Comparison of exhaust gas and blood concentration of isoflurane

    Exhaust gas and blood concentrations of isoflurane will be recorded at three time points during the operation. These values will be compared to see if their values are are related.

    Time frame: Intraoperative

  2. Comparison of blood isoflurane concentration and BIS score

    Blood isoflurane concentration and BIS will be recorded at three time points and compared to see if they are related

    Time frame: Intraoperative

  3. Comparison of exhaust isoflurane Concentration and BIS score

    Exhaust isoflurane and BIS will be recorded at three time points and compared to see they are related.

    Time frame: Intraoperative

07

Study locations

1 site
  • Royal Infirmary of Edinburgh
    Edinburgh, Scotland EH16 4SA, United Kingdom
08

References and documents

Publications

  • Alston RP, Connelly M, MacKenzie C, Just G, Homer N. The depth of anaesthesia associated with the administration of isoflurane 2.5% during cardiopulmonary bypass. Perfusion. 2019 Jul;34(5):392-398. doi: 10.1177/0267659118822946. Epub 2019 Jan 12. PubMed 30638148 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 21, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02471950
Lead sponsor
University of Edinburgh
Responsible party
Sponsor
First posted
Jun 15, 2015
Start date
Apr 2015
Primary completion
Jan 2019
Completion
Jan 2019
Last update
Jun 21, 2021

Study contacts

Peter Alston, MBChB
principal investigator · University of Edinburgh

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion